Agile Therapeutics Quick Ratio 2013-2023 | AGRX
Historical quick ratio values for Agile Therapeutics (AGRX) over the last 10 years.
| Agile Therapeutics Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2023-12-31 |
$0.01B |
$0.02B |
0.33 |
| 2023-09-30 |
$0.01B |
$0.02B |
0.44 |
| 2023-06-30 |
$0.01B |
$0.02B |
0.60 |
| 2023-03-31 |
$0.01B |
$0.02B |
0.47 |
| 2022-12-31 |
$0.01B |
$0.01B |
0.75 |
| 2022-09-30 |
$0.01B |
$0.01B |
1.18 |
| 2022-06-30 |
$0.02B |
$0.03B |
0.56 |
| 2022-03-31 |
$0.01B |
$0.03B |
0.45 |
| 2021-12-31 |
$0.02B |
$0.03B |
0.78 |
| 2021-09-30 |
$0.02B |
$0.01B |
1.91 |
| 2021-06-30 |
$0.03B |
$0.01B |
2.88 |
| 2021-03-31 |
$0.04B |
$0.01B |
4.79 |
| 2020-12-31 |
$0.00B |
$0.01B |
0.00 |
| 2020-09-30 |
$0.00B |
$0.01B |
0.00 |
| 2020-06-30 |
$0.00B |
$0.01B |
0.00 |
| 2020-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2019-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2019-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2019-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2019-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2018-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2018-09-30 |
$0.00B |
$0.01B |
0.00 |
| 2018-06-30 |
$0.00B |
$0.01B |
0.00 |
| 2018-03-31 |
$0.00B |
$0.01B |
0.00 |
| 2017-12-31 |
$0.00B |
$0.01B |
0.00 |
| 2017-09-30 |
$0.00B |
$0.01B |
0.00 |
| 2017-06-30 |
$0.00B |
$0.01B |
0.00 |
| 2017-03-31 |
$0.00B |
$0.01B |
0.00 |
| 2016-12-31 |
$0.00B |
$0.01B |
0.00 |
| 2016-09-30 |
$0.00B |
$0.01B |
0.00 |
| 2016-06-30 |
$0.00B |
$0.01B |
0.00 |
| 2016-03-31 |
$0.00B |
$0.01B |
0.00 |
| 2015-12-31 |
$0.00B |
$0.01B |
0.00 |
| 2015-09-30 |
$0.00B |
$0.01B |
0.00 |
| 2015-06-30 |
$0.00B |
$0.01B |
0.00 |
| 2015-03-31 |
$0.00B |
$0.01B |
0.00 |
| 2014-12-31 |
$0.00B |
$0.01B |
0.00 |
| 2014-09-30 |
$0.00B |
$0.01B |
0.00 |
| 2014-06-30 |
$0.00B |
$0.01B |
0.00 |
| 2014-03-31 |
$0.00B |
|
0.00 |
| 2013-12-31 |
$0.00B |
|
0.00 |
| 2013-09-30 |
$0.00B |
|
0.00 |
| 2013-06-30 |
$0.00B |
|
0.00 |
| 2012-12-31 |
$0.00B |
$0.00B |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.003B |
$0.020B |
|
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
|
